SE451842B - Vattenlosliga 3-formylrifamycin-sv-hydrazoner samt farmaceutiska kompositioner innehallande dessa substanser - Google Patents

Vattenlosliga 3-formylrifamycin-sv-hydrazoner samt farmaceutiska kompositioner innehallande dessa substanser

Info

Publication number
SE451842B
SE451842B SE8004739A SE8004739A SE451842B SE 451842 B SE451842 B SE 451842B SE 8004739 A SE8004739 A SE 8004739A SE 8004739 A SE8004739 A SE 8004739A SE 451842 B SE451842 B SE 451842B
Authority
SE
Sweden
Prior art keywords
water
represents hydrogen
formula
rifamycin
formylrifamycin
Prior art date
Application number
SE8004739A
Other languages
English (en)
Swedish (sv)
Other versions
SE8004739L (sv
Inventor
R Cricchio
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of SE8004739L publication Critical patent/SE8004739L/
Publication of SE451842B publication Critical patent/SE451842B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE8004739A 1979-06-28 1980-06-26 Vattenlosliga 3-formylrifamycin-sv-hydrazoner samt farmaceutiska kompositioner innehallande dessa substanser SE451842B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7922461 1979-06-28

Publications (2)

Publication Number Publication Date
SE8004739L SE8004739L (sv) 1980-12-29
SE451842B true SE451842B (sv) 1987-11-02

Family

ID=10506154

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8004739A SE451842B (sv) 1979-06-28 1980-06-26 Vattenlosliga 3-formylrifamycin-sv-hydrazoner samt farmaceutiska kompositioner innehallande dessa substanser

Country Status (18)

Country Link
US (1) US4271155A (xx)
JP (1) JPS5618993A (xx)
KR (1) KR830002533B1 (xx)
AR (1) AR225181A1 (xx)
AU (1) AU536524B2 (xx)
CA (1) CA1114814A (xx)
DE (1) DE3024304A1 (xx)
DK (1) DK155742C (xx)
FR (1) FR2460304A1 (xx)
GB (1) GB2051815B (xx)
HK (1) HK23684A (xx)
IE (1) IE49930B1 (xx)
IT (1) IT1209333B (xx)
NL (1) NL8003527A (xx)
NZ (1) NZ194144A (xx)
PH (1) PH15769A (xx)
SE (1) SE451842B (xx)
ZA (1) ZA803635B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300924B2 (en) * 2003-04-25 2007-11-27 Gilead Sciences, Inc. Anti-infective phosphonate analogs
WO2007096703A2 (en) * 2005-08-11 2007-08-30 Targanta Therapeutics Inc. Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR208F (xx) * 1964-07-31
FR5223M (xx) * 1965-11-12 1967-07-10
US4005076A (en) * 1971-06-24 1977-01-25 Gruppo Lepetit S.P.A. Hydrazones of 3-formylrifamycin SV
BE794100A (fr) * 1972-02-23 1973-05-16 Lepetit Spa Derives 3-hydrazonomethyles de rifamycine et leur preparation
AR205434A1 (es) * 1972-03-27 1976-05-07 Lepetit Spa Proceso para la preparacion de 3-acilhidrazonometil rifamicinas sv
GB1486118A (en) * 1975-03-05 1977-09-21 Lepetit Spa Rifamycin derivatives
GB1478563A (en) * 1975-03-05 1977-07-06 Lepetit Spa Rifamycin derivatives
GR64108B (en) * 1977-04-15 1980-01-24 Dso Pharmachim Method for the preparation of azomethine-derivatives of rifamycin s.v

Also Published As

Publication number Publication date
GB2051815B (en) 1983-07-06
GB2051815A (en) 1981-01-21
ZA803635B (en) 1981-06-24
IE801346L (en) 1980-12-28
SE8004739L (sv) 1980-12-29
IE49930B1 (en) 1986-01-08
IT1209333B (it) 1989-07-16
FR2460304A1 (fr) 1981-01-23
AU536524B2 (en) 1984-05-10
US4271155A (en) 1981-06-02
DK155742B (da) 1989-05-08
DK269380A (da) 1980-12-29
NZ194144A (en) 1984-05-31
HK23684A (en) 1984-03-23
KR830002533B1 (ko) 1983-11-12
AR225181A1 (es) 1982-02-26
CA1114814A (en) 1981-12-22
PH15769A (en) 1983-03-24
FR2460304B1 (xx) 1984-07-27
DE3024304C2 (xx) 1991-10-31
AU5918880A (en) 1981-01-08
DK155742C (da) 1989-09-18
JPS6348877B2 (xx) 1988-09-30
NL8003527A (nl) 1980-12-30
IT8022817A0 (it) 1980-06-17
KR830002767A (ko) 1983-05-30
JPS5618993A (en) 1981-02-23
DE3024304A1 (de) 1981-02-05

Similar Documents

Publication Publication Date Title
US7915303B2 (en) Glycopyrronium salts and their therapeutic use
EP3978472A1 (en) Biaryl monabactam compounds and methods of use thereof for the treatment of bacterial infections
CA1283656C (en) Deoxyadenosine phosphate compounds and methods of making and using the same
DE68906183T2 (de) 2'-desoxy-5-fluoruridinderivate.
EP2020416A1 (en) Phosphonocephem compound
PT89009B (pt) Processo para a preparacao de novos derivados de fluorocitidina e composicoes farmaceuticas que os contem'
US4512998A (en) Anthelmintic benzimidazole carbamates
SU1604158A3 (ru) Способ получени производных гризеоловой кислоты
Fletcher et al. Preparation of O, O-diethyl Op-nitrophenyl thiophosphate (parathion)
US4636508A (en) 5-pyrimidinecarboxyamides and treatment of leukemia therewith
GB1599928A (en) Process for producing glycopyranosenitrosourea compounds and a compound included therein
US4727065A (en) Bis-(2-ammonium-2-hydroxymethyl-1,3-propanediol(2R-cis)-(3-methyloxiranyl)-phosphonate, a method of preparing same, and pharmaceutical compositions containing same
EP0027597B1 (en) Mono(2-ammonium-2-hydroxymethyl-1,3-propanediol)(2r-cis)-(3-methyloxiranyl)phosphonate, its preparation and pharmaceutical compositions containing it
US4406893A (en) N-Alkoxycarbonyl-N'-[2-nitro-4 or 5-alkylthiophenyl]-N"-[substituted alkyl]-guanidines useful as anthelmintics
KR0178956B1 (ko) 항균성 페넴 에스테르 유도체
US4002754A (en) Substituted piperazinyliminorifamycins
SE451842B (sv) Vattenlosliga 3-formylrifamycin-sv-hydrazoner samt farmaceutiska kompositioner innehallande dessa substanser
US4567169A (en) Nitrosourea substituted phosphonates and pharmaceutical use
EP1284984B1 (fr) Derives de l'uridine comme antibiotiques
US4544501A (en) Bis(2,2-dimethyl-1-aziridinyl)phosphinic amides for use in the treatment of tumors
DE69815380T2 (de) N,n'-bis (sulfonyl) hydrazine die als antineoplastische mittel nützlich sind
US4386084A (en) N-Pyrimidinyl-carbamic acid esters, their preparation, and drugs containing these compounds
PL170798B1 (pl) Sposób wytwarzania krystalicznych soli addycyjnych z kwasem obydwóch poszczególnych diastereomerówestru 1-(2,2-dimetylopropionyloksy)-etylowego kwasu 3-cefem-4-karboksylowego PL PL
US4920126A (en) Barbituric acid derivative and treatment of leukemia and tumors therewith
HU197568B (en) Process for producing crystalline salts of square brackets open 3siz square brackets closed-2-brackets open square brackets open square brackets open 1-/2-amino-4-thiazolyl/-2-square brackets open square brackets open 2,2-dimethyl-4-oxo-1-sulfoxy-3-azetidinyl square brackets closed-amino square brackets closed-2-oxoehtylidene square brackets closed-amino square brackets closed-oxy brackets closed acetic acid and pharmaceuticals comprising same as active ingredient

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8004739-2

Effective date: 19950110

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8004739-2

Format of ref document f/p: F